{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T10:54:32Z","timestamp":1773140072800,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00108-024-01783-3","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T17:02:45Z","timestamp":1727715765000},"page":"1273-1282","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Eisenmangel bei kardiovaskul\u00e4ren Erkrankungen","Iron deficiency in cardiovascular disease"],"prefix":"10.1007","volume":"65","author":[{"given":"Stephan","family":"von Haehling","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"issue":"7","key":"1783_CR1","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1016\/s0735-1097(00)00613-6","volume":"35","author":"DS Silverberg","year":"2000","unstructured":"Silverberg\u00a0DS, Wexler\u00a0D, Blum\u00a0M, Keren\u00a0G, Sheps\u00a0D, Leibovitch\u00a0E, Brosh\u00a0D, Laniado\u00a0S, Schwartz\u00a0D, Yachnin\u00a0T, Shapira\u00a0I, Gavish\u00a0D, Baruch\u00a0R, Koifman\u00a0B, Kaplan\u00a0C, Steinbruch\u00a0S, Iaina\u00a0A (2000) The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J\u00a0Am Coll Cardiol 35(7):1737\u20131744. https:\/\/doi.org\/10.1016\/s0735-1097(00)00613-6","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"1783_CR2","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3390\/nu15061387","volume":"15","author":"GA Plotnikoff","year":"2023","unstructured":"Plotnikoff\u00a0GA, Dobberstein\u00a0L, Raatz\u00a0S (2023) Nutritional assessment of the symptomatic patient on a\u00a0plant-based diet: seven key questions. Nutrients 15(6):1387. https:\/\/doi.org\/10.3390\/nu15061387","journal-title":"Nutrients"},{"issue":"11","key":"1783_CR3","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrcardio.2015.109","volume":"12","author":"S von Haehling","year":"2015","unstructured":"von Haehling\u00a0S, Jankowska\u00a0EA, van Veldhuisen\u00a0DJ, Ponikowski\u00a0P, Anker\u00a0SD (2015) Iron deficiency and cardiovascular disease. Nat Rev Cardiol 12(11):659\u2013669. https:\/\/doi.org\/10.1038\/nrcardio.2015.109","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"1783_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00108-017-0242-z","volume":"58","author":"S von Haehling","year":"2017","unstructured":"von Haehling\u00a0S, Ottenjann\u00a0H, Anker\u00a0SD (2017) Eisenmangel : Erkennen und behandeln. Internist 58(6):627\u2013638. https:\/\/doi.org\/10.1007\/s00108-017-0242-z","journal-title":"Internist"},{"issue":"1","key":"1783_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/ejhf.3024","volume":"26","author":"TA McDonagh","year":"2024","unstructured":"McDonagh\u00a0TA, Metra\u00a0M, Adamo\u00a0M, Gardner\u00a0RS, Baumbach\u00a0A, B\u00f6hm\u00a0M, Burri\u00a0H, Butler\u00a0J, \u010celutkien\u0117\u00a0J, Chioncel\u00a0O, Cleland\u00a0JGF, Crespo-Leiro\u00a0MG, Farmakis\u00a0D, Gilard\u00a0M, Heymans\u00a0S, Hoes\u00a0AW, Jaarsma\u00a0T, Jankowska\u00a0EA, Lainscak\u00a0M, Lam\u00a0CSP, Lyon\u00a0AR, McMurray\u00a0JJV, Mebazaa\u00a0A, Mindham\u00a0R, Muneretto\u00a0C, Piepoli Francesco\u00a0M, Price\u00a0S, Rosano\u00a0GMC, Ruschitzka\u00a0F, Skibelund\u00a0AK, ESC Scientific Document Group (2024) 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 26(1):5\u201317. https:\/\/doi.org\/10.1002\/ejhf.3024","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"1783_CR6","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1002\/ehf2.14438","volume":"10","author":"FJ Graham","year":"2023","unstructured":"Graham\u00a0FJ, Pellicori\u00a0P, Masini\u00a0G, Cuthbert\u00a0JJ, Clark\u00a0AL, Cleland\u00a0JGF (2023) Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure. ESC Heart Fail 10(5):2826\u20132836. https:\/\/doi.org\/10.1002\/ehf2.14438","journal-title":"ESC Heart Fail"},{"issue":"2","key":"1783_CR7","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/ehf2.14265","volume":"10","author":"A Tada","year":"2023","unstructured":"Tada\u00a0A, Nagai\u00a0T, Koya\u00a0T, Nakao\u00a0M, Ishizaka\u00a0S, Mizuguchi\u00a0Y, Aoyagi\u00a0H, Imagawa\u00a0S, Tokuda\u00a0Y, Takahashi\u00a0M, Kato\u00a0Y, Machida\u00a0M, Matsutani\u00a0K, Saito\u00a0T, Anzai\u00a0T, ELMSTAT-HF investigators (2023) Applicability of new proposed criteria for iron deficiency in Japanese patients with heart failure. ESC Heart Fail 10(2):985\u2013994. https:\/\/doi.org\/10.1002\/ehf2.14265","journal-title":"ESC Heart Fail"},{"issue":"6","key":"1783_CR8","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s00392-016-1073-y","volume":"106","author":"S von Haehling","year":"2017","unstructured":"von Haehling\u00a0S, Gremmler\u00a0U, Krumm\u00a0M, Mibach\u00a0F, Sch\u00f6n\u00a0N, Taggeselle\u00a0J, Dahm\u00a0JB, Angermann\u00a0CE (2017) Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP registry. Clin Res Cardiol 106(6):436\u2013443. https:\/\/doi.org\/10.1007\/s00392-016-1073-y","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"1783_CR9","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ehf2.13850","volume":"9","author":"A Cohen-Solal","year":"2022","unstructured":"Cohen-Solal\u00a0A, Philip\u00a0JL, Picard\u00a0F, Delarche\u00a0N, Taldir\u00a0G, Gzara\u00a0H, Korichi\u00a0A, Trochu\u00a0JN, Cacoub\u00a0P, CARENFER Study Group (2022) Iron deficiency in heart failure patients: the French CARENFER prospective study. ESC Heart Fail 9(2):874\u2013884. https:\/\/doi.org\/10.1002\/ehf2.13850","journal-title":"ESC Heart Fail"},{"issue":"19","key":"1783_CR10","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1001\/jama.2017.5427","volume":"317","author":"GD Lewis","year":"2017","unstructured":"Lewis\u00a0GD, Malhotra\u00a0R, Hernandez\u00a0AF, McNulty\u00a0SE, Smith\u00a0A, Felker\u00a0GM, Tang\u00a0WHW, LaRue\u00a0SJ, Redfield\u00a0MM, Semigran\u00a0MJ, Givertz\u00a0MM, Van Buren\u00a0P, Whellan\u00a0D, Anstrom\u00a0KJ, Shah\u00a0MR, Desvigne-Nickens\u00a0P, Butler\u00a0J, Braunwald\u00a0E, NHLBI Heart Failure Clinical Research Network (2017) Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA 317(19):1958\u20131966. https:\/\/doi.org\/10.1001\/jama.2017.5427 (Erratum in: JAMA. 2017 Jun 20;317(23):2453)","journal-title":"JAMA"},{"key":"1783_CR11","doi-asserted-by":"publisher","unstructured":"von Haehling\u00a0S, Ebner\u00a0N, Evertz\u00a0R, Ponikowski\u00a0P, Anker\u00a0SD (2019) Iron Deficiency in Heart Failure: An Overview. JACC Heart Fail 7(1):36\u201346. https:\/\/doi.org\/10.1016\/j.jchf.2018.07.015. Epub 2018 Dec 12. PMID: 30553903","DOI":"10.1016\/j.jchf.2018.07.015"},{"issue":"25","key":"1783_CR12","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","volume":"361","author":"SD Anker","year":"2009","unstructured":"Anker\u00a0SD, Comin Colet\u00a0J, Filippatos\u00a0G, Willenheimer\u00a0R, Dickstein\u00a0K, Drexler\u00a0H, L\u00fcscher\u00a0TF, Bart\u00a0B, Banasiak\u00a0W, Niegowska\u00a0J, Kirwan\u00a0BA, Mori\u00a0C, von Eisenhart Rothe\u00a0B, Pocock\u00a0SJ, Poole-Wilson\u00a0PA, Ponikowski\u00a0P, FAIR-HF Trial Investigators (2009) Ferric carboxymaltose in patients with heart failure and iron deficiency. N\u00a0Engl J Med 361(25):2436\u20132448. https:\/\/doi.org\/10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"issue":"11","key":"1783_CR13","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","volume":"36","author":"P Ponikowski","year":"2015","unstructured":"Ponikowski\u00a0P, van Veldhuisen\u00a0DJ, Comin-Colet\u00a0J, Ertl\u00a0G, Komajda\u00a0M, Mareev\u00a0V, McDonagh\u00a0T, Parkhomenko\u00a0A, Tavazzi\u00a0L, Levesque\u00a0V, Mori\u00a0C, Roubert\u00a0B, Filippatos\u00a0G, Ruschitzka\u00a0F, Anker\u00a0SD, CONFIRM-HF Investigators (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. Eur Heart\u00a0J 36(11):657\u2013668. https:\/\/doi.org\/10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"issue":"15","key":"1783_CR14","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1161\/CIRCULATIONAHA.117.027497","volume":"136","author":"DJ van Veldhuisen","year":"2017","unstructured":"van Veldhuisen\u00a0DJ, Ponikowski\u00a0P, van der Meer\u00a0P, Metra\u00a0M, B\u00f6hm\u00a0M, Doletsky\u00a0A, Voors\u00a0AA, Macdougall\u00a0IC, Anker\u00a0SD, Roubert\u00a0B, Zakin\u00a0L, Cohen-Solal\u00a0A, EFFECT-HF Investigators (2017) Effect of ferric carboxymaltose on exercise capacity in patients with chronic heart failure and iron deficiency. Circulation 136(15):1374\u20131383. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.027497","journal-title":"Circulation"},{"key":"1783_CR15","doi-asserted-by":"publisher","unstructured":"McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, B\u00f6hm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, K\u00f8ber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, R\u00f8nnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A; Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology; Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2012 Aug;14(8):803\u201369. https:\/\/doi.org\/10.1093\/eurjhf\/hfs105. Erratum in: Eur J Heart Fail. 2013 Mar;15(3):361\u20132. PMID: 22828712.","DOI":"10.1093\/eurjhf\/hfs105"},{"issue":"10266","key":"1783_CR16","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","volume":"396","author":"P Ponikowski","year":"2020","unstructured":"Ponikowski\u00a0P, Kirwan\u00a0BA, Anker\u00a0SD, McDonagh\u00a0T, Dorobantu\u00a0M, Drozdz\u00a0J, Fabien\u00a0V, Filippatos\u00a0G, G\u00f6hring\u00a0UM, Keren\u00a0A, Khintibidze\u00a0I, Kragten\u00a0H, Martinez\u00a0FA, Metra\u00a0M, Milicic\u00a0D, Nicolau\u00a0JC, Ohlsson\u00a0M, Parkhomenko\u00a0A, Pascual-Figal\u00a0DA, Ruschitzka\u00a0F, Sim\u00a0D, Skouri\u00a0H, van der Meer\u00a0P, Lewis\u00a0BS, Comin-Colet\u00a0J, von Haehling\u00a0S, Cohen-Solal\u00a0A, Danchin\u00a0N, Doehner\u00a0W, Dargie\u00a0HJ, Motro\u00a0M, Butler\u00a0J, Friede\u00a0T, Jensen\u00a0KH, Pocock\u00a0S, Jankowska\u00a0EA, AFFIRM-AHF investigators (2020) Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet 396(10266):1895\u20131904. https:\/\/doi.org\/10.1016\/S0140-6736(20)32339-4 (Erratum in: Lancet. 2021 Nov 27;398(10315):1964. https:\/\/doi.org\/10.1016\/S0140-6736(21)02492-2)","journal-title":"Lancet"},{"issue":"10369","key":"1783_CR17","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","volume":"400","author":"PR Kalra","year":"2022","unstructured":"Kalra\u00a0PR, Cleland\u00a0JGF, Petrie\u00a0MC, Thomson\u00a0EA, Kalra\u00a0PA, Squire\u00a0IB, Ahmed\u00a0FZ, Al-Mohammad\u00a0A, Cowburn\u00a0PJ, Foley\u00a0PWX, Graham\u00a0FJ, Japp\u00a0AG, Lane\u00a0RE, Lang\u00a0NN, Ludman\u00a0AJ, Macdougall\u00a0IC, Pellicori\u00a0P, Ray\u00a0R, Robertson\u00a0M, Seed\u00a0A, Ford\u00a0I, IRONMAN Study Group (2022) Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet 400(10369):2199\u20132209. https:\/\/doi.org\/10.1016\/S0140-6736(22)02083-9","journal-title":"Lancet"},{"issue":"11","key":"1783_CR18","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","volume":"389","author":"RJ Mentz","year":"2023","unstructured":"Mentz\u00a0RJ, Garg\u00a0J, Rockhold\u00a0FW, Butler\u00a0J, De Pasquale\u00a0CG, Ezekowitz\u00a0JA, Lewis\u00a0GD, O\u2019Meara\u00a0E, Ponikowski\u00a0P, Troughton\u00a0RW, Wong\u00a0YW, She\u00a0L, Harrington\u00a0J, Adamczyk\u00a0R, Blackman\u00a0N, Hernandez\u00a0AF, HEART-FID Investigators (2023) Ferric carboxymaltose in heart failure with iron deficiency. N\u00a0Engl J Med 389(11):975\u2013986. https:\/\/doi.org\/10.1056\/NEJMoa2304968","journal-title":"N Engl J Med"},{"key":"1783_CR19","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-024-02396-4","author":"S von Haehling","year":"2024","unstructured":"von Haehling\u00a0S, Assmus\u00a0B, Bekfani\u00a0T, Dworatzek\u00a0E, Edelmann\u00a0F, Hashemi\u00a0D, Hellenkamp\u00a0K, Kempf\u00a0T, Raake\u00a0P, Sch\u00fctt\u00a0KA, Wachter\u00a0R, Schulze\u00a0PC, Hasenfuss\u00a0G, B\u00f6hm\u00a0M, Bauersachs\u00a0J (2024) Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-024-02396-4","journal-title":"Clin Res Cardiol"},{"key":"1783_CR20","doi-asserted-by":"publisher","unstructured":"von Haehling\u00a0S, Doehner\u00a0W, Evertz\u00a0R, Garfias-Veitl\u00a0T, Derad\u00a0C, Diek\u00a0M, Karakas\u00a0M, Birkemeyer\u00a0R, Fillippatos\u00a0G, Lainscak\u00a0M, Butler\u00a0J, Ponikowski\u00a0P, B\u00f6hm\u00a0M, Friede\u00a0T, Anker\u00a0SD (2024) Ferric carboxymaltose and exercise capacity in heart failure with preserved ejection fraction and iron deficiency: the FAIR-HFpEF trial. Eur Heart J. 2024 Aug 26:ehae479. https:\/\/doi.org\/10.1093\/eurheartj\/ehae479. Epub ahead of print. PMID: 39185895","DOI":"10.1093\/eurheartj\/ehae479"},{"issue":"1","key":"1783_CR21","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/ejhf.1838","volume":"23","author":"S von Haehling","year":"2021","unstructured":"von Haehling\u00a0S, Arzt\u00a0M, Doehner\u00a0W, Edelmann\u00a0F, Evertz\u00a0R, Ebner\u00a0N, Herrmann-Lingen\u00a0C, Garfias Macedo\u00a0T, Koziolek\u00a0M, Noutsias\u00a0M, Schulze\u00a0PC, Wachter\u00a0R, Hasenfu\u00df\u00a0G, Laufs\u00a0U (2021) Improving exercise capacity and quality of life using non-invasive heart failure treatments: evidence from clinical trials. Eur J Heart Fail 23(1):92\u2013113. https:\/\/doi.org\/10.1002\/ejhf.1838","journal-title":"Eur J Heart Fail"},{"key":"1783_CR22","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.ijcard.2017.06.024","volume":"244","author":"T Rheude","year":"2017","unstructured":"Rheude\u00a0T, Pellegrini\u00a0C, Michel\u00a0J, Trenkwalder\u00a0T, Mayr\u00a0NP, Kessler\u00a0T, Kasel\u00a0AM, Schunkert\u00a0H, Kastrati\u00a0A, Hengstenberg\u00a0C, Husser\u00a0O (2017) Prognostic impact of anemia and iron-deficiency anemia in a contemporary cohort of patients undergoing transcatheter aortic valve implantation. Int J Cardiol 244:93\u201399. https:\/\/doi.org\/10.1016\/j.ijcard.2017.06.024","journal-title":"Int J Cardiol"},{"issue":"9","key":"1783_CR23","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.amjcard.2019.07.051","volume":"124","author":"T Rheude","year":"2019","unstructured":"Rheude\u00a0T, Pellegrini\u00a0C, Lessmann\u00a0L, Wiebe\u00a0J, Mayr\u00a0NP, Michel\u00a0J, Trenkwalder\u00a0T, Kasel\u00a0AM, Schunkert\u00a0H, Kastrati\u00a0A, Joner\u00a0M, Husser\u00a0O, Hengstenberg\u00a0C (2019) Prevalence and clinical impact of iron deficiency in patients with severe aortic stenosis referred for transcatheter aortic valve implantation. Am J Cardiol 124(9):1442\u20131448. https:\/\/doi.org\/10.1016\/j.amjcard.2019.07.051","journal-title":"Am J Cardiol"},{"issue":"2","key":"1783_CR24","doi-asserted-by":"publisher","first-page":"e000901","DOI":"10.1136\/openhrt-2018-000901","volume":"5","author":"AB Kvaslerud","year":"2018","unstructured":"Kvaslerud\u00a0AB, Hussain\u00a0AI, Auensen\u00a0A, Ueland\u00a0T, Michelsen\u00a0AE, Pettersen\u00a0KI, Aukrust\u00a0P, M\u00f8rkrid\u00a0L, Gullestad\u00a0L, Broch\u00a0K (2018) Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis. Open Heart 5(2):e901. https:\/\/doi.org\/10.1136\/openhrt-2018-000901","journal-title":"Open Heart"},{"key":"1783_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-023-02276-3","author":"AA Al-Mubarak","year":"2023","unstructured":"Al-Mubarak\u00a0AA, Grote Beverborg\u00a0N, Zwartkruis\u00a0V, van Deutekom\u00a0C, de Borst\u00a0MH, Gansevoort\u00a0RT, Bakker\u00a0SJL, Touw\u00a0DJ, de Boer\u00a0RA, van der Meer\u00a0P, Rienstra\u00a0M, Bomer\u00a0N (2023) Micronutrient deficiencies and new-onset atrial fibrillation in a community-based cohort: data from PREVEND. Clin Res Cardiol. https:\/\/doi.org\/10.1007\/s00392-023-02276-3","journal-title":"Clin Res Cardiol"},{"issue":"10","key":"1783_CR26","doi-asserted-by":"publisher","first-page":"101001","DOI":"10.1016\/j.cpcardiol.2021.101001","volume":"47","author":"AMK Minhas","year":"2022","unstructured":"Minhas\u00a0AMK, Sagheer\u00a0S, Shekhar\u00a0R, Sheikh\u00a0AB, Nazir\u00a0S, Ullah\u00a0W, Khan\u00a0MZ, Shahid\u00a0I, Dani\u00a0SS, Michos\u00a0ED, Fudim\u00a0M (2022) Trends and inpatient outcomes of primary atrial fibrillation hospitalizations with underlying iron deficiency anemia: an analysis of the national inpatient sample database from 2004\u20132018. Curr Probl Cardiol 47(10):101001. https:\/\/doi.org\/10.1016\/j.cpcardiol.2021.101001","journal-title":"Curr Probl Cardiol"},{"issue":"2","key":"1783_CR27","doi-asserted-by":"publisher","first-page":"103","DOI":"10.5543\/tkda.2018.51001","volume":"46","author":"M Keskin","year":"2018","unstructured":"Keskin\u00a0M, Ural\u00a0D, Altay\u00a0S, Argan\u00a0O, B\u00f6rkl\u00fc\u00a0EB, Kozan \u00d6 (2018) Iron deficiency and hematinic deficiencies in atrial fibrillation: a new insight into comorbidities. Turk Kardiyol Dern Ars 46(2):103\u2013110. https:\/\/doi.org\/10.5543\/tkda.2018.51001","journal-title":"Turk Kardiyol Dern Ars"},{"issue":"8","key":"1783_CR28","doi-asserted-by":"publisher","first-page":"e047642","DOI":"10.1136\/bmjopen-2020-047642","volume":"11","author":"SJ Tu","year":"2021","unstructured":"Tu\u00a0SJ, Elliott\u00a0AD, Hanna-Rivero\u00a0N, Gallagher\u00a0C, Mishima\u00a0RS, Lyrtzis\u00a0E, Wlochowicz\u00a0D, Clarke\u00a0NA, Roberts-Thomson\u00a0KC, Stokes\u00a0MB, Emami\u00a0M, Lau\u00a0DH, Sanders\u00a0P, Wong\u00a0CX (2021) Rationale and design of the IRON-AF study: a double-blind, randomised, placebo-controlled study to assess the effect of intravenous ferric carboxymaltose in patients with atrial fibrillation and iron deficiency. BMJ Open 11(8):e47642. https:\/\/doi.org\/10.1136\/bmjopen-2020-047642","journal-title":"BMJ Open"},{"issue":"4","key":"1783_CR29","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.hrtlng.2018.05.002","volume":"47","author":"X Yu","year":"2018","unstructured":"Yu\u00a0X, Luo\u00a0Q, Liu\u00a0Z, Zhao\u00a0Z, Zhao\u00a0Q, An\u00a0C, Huang\u00a0Z, Jin\u00a0Q, Gao\u00a0L, Yan\u00a0L (2018) Prevalence of iron deficiency in different subtypes of pulmonary hypertension. Heart Lung 47(4):308\u2013313. https:\/\/doi.org\/10.1016\/j.hrtlng.2018.05.002","journal-title":"Heart Lung"},{"issue":"1","key":"1783_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/eurheartj\/ehac569","volume":"44","author":"G Savarese","year":"2023","unstructured":"Savarese\u00a0G, von Haehling\u00a0S, Butler\u00a0J, Cleland\u00a0JGF, Ponikowski\u00a0P, Anker\u00a0SD (2023) Iron deficiency and cardiovascular disease. Eur Heart\u00a0J 44(1):14\u201327. https:\/\/doi.org\/10.1093\/eurheartj\/ehac569 (Erratum in: Eur Heart J. 2023 May 7;44(18):1607. https:\/\/doi.org\/10.1093\/eurheartj\/ehad043)","journal-title":"Eur Heart J"},{"issue":"2","key":"1783_CR31","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ijcard.2014.04.233","volume":"175","author":"T Viethen","year":"2014","unstructured":"Viethen\u00a0T, Gerhardt\u00a0F, Dumitrescu\u00a0D, Knoop-Busch\u00a0S, ten Freyhaus\u00a0H, Rudolph\u00a0TK, Baldus\u00a0S, Rosenkranz\u00a0S (2014) Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study. Int J Cardiol 175(2):233\u2013239. https:\/\/doi.org\/10.1016\/j.ijcard.2014.04.233","journal-title":"Int J Cardiol"},{"issue":"3","key":"1783_CR32","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1086\/682217","volume":"5","author":"G Ruiter","year":"2015","unstructured":"Ruiter\u00a0G, Manders\u00a0E, Happ\u00e9\u00a0CM, Schalij\u00a0I, Groepenhoff\u00a0H, Howard\u00a0LS, Wilkins\u00a0MR, Bogaard\u00a0HJ, Westerhof\u00a0N, van der Laarse\u00a0WJ, de Man\u00a0FS, Vonk-Noordegraaf\u00a0A (2015) Intravenous iron therapy in patients with idiopathic pulmonary arterial hypertension and iron deficiency. Pulm circ 5(3):466\u2013472. https:\/\/doi.org\/10.1086\/682217","journal-title":"Pulm circ"},{"issue":"7","key":"1783_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.5543\/tkda.2022.22343","volume":"50","author":"D Akaslan","year":"2022","unstructured":"Akaslan\u00a0D, Aslanger\u00a0E, Ata\u015f\u00a0H, Kanar\u00a0BG, Kocakaya\u00a0D, Y\u0131ld\u0131zeli\u00a0B, Mutlu\u00a0B (2022) The effects of iron replacement on functional capacity in patients with group 1 and group 4 pulmonary hypertension. Turk Kardiyol Dern Ars 50(7):492\u2013497. https:\/\/doi.org\/10.5543\/tkda.2022.22343 (PMID: 36200717)","journal-title":"Turk Kardiyol Dern Ars"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01783-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-024-01783-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-024-01783-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T22:03:07Z","timestamp":1733868187000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-024-01783-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1007\/s00108-024-01783-3","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"value":"2731-7080","type":"print"},{"value":"2731-7099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"assertion":[{"value":"14 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0von Haehling ist Berater f\u00fcr und\/oder erhielt Honorzahlungen von AstraZeneca, Bayer, Boehringer Ingelheim, BRAHMS, Edwards Lifesciences, MSD, Novartis, Novo Nordisk, Pfizer, Pharmacosmos, und Vifor. Er erh\u00e4lt Forschungsunterst\u00fctzung von IMI, dem Deutschen Zentrum f\u00fcr Herz- und Kreislauf-Forschung e.\u202fV. (DZHK) sowie von Amgen, AstraZeneca, Boehringer-Ingelheim, Novo Nordisk und Pharmacosmos.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}